News
News Releases
Belfer family¡¯s $20 million donation invigorates neurodegeneration research at MD Anderson
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
MD Anderson Research Highlights for February 1, 2023
Androgen receptor signaling contributes to targeted therapy resistance in melanoma
Research Highlights for June 1, 2022
Novel therapy could help people with asthma, COPD, cystic fibrosis and cancer-related lung disease
Research Highlights for March 9, 2022
Research Highlights for February 9, 2022
Research Highlights SITC 2021 Special Edition
Research Highlights for October 20, 2021
Research Highlights for September 22, 2021
Research Highlights for August 25, 2021
MD Anderson and Broad Institute launch new translational research platform focused on rare cancers
MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
$24 million in CPRIT funding awarded to MD Anderson and related research
Triple negative breast cancers can adopt reversible state that is resistant to chemotherapy
Giulio Draetta named Chief Scientific Officer
New therapeutic target found for aggressive pediatric cancers with few treatment options
MD Anderson and Ipsen announce joint bench-to-bedside cancer drug development partnership